Segment Information (Tables)

12 Months Ended

Dec. 31, 2021

The following tables contain certain financial information by geographic area:


	December 31, 2021
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	3,805.7	$	2,626.0	$	1,162.4	$	688.0	$	564.8	$	8,846.9
Revenue from anti-CD20 therapeutic programs	1,596.7		—		—		—		61.8		1,658.5
Other revenue from external customers	429.9		9.7		—		36.7		—		476.3
Long-lived assets	1,390.5		2,337.8		25.4		16.4		21.7		3,791.8

	December 31, 2020
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	5,900.1	$	2,495.3	$	1,161.1	$	596.7	$	539.0	$	10,692.2
Revenue from anti-CD20 therapeutic programs	1,897.4		0.1		—		—		80.3		1,977.8
Other revenue from external customers	733.6		8.0		0.1		32.9		—		774.6
Long-lived assets	1,496.3		2,290.2		31.2		16.2		10.9		3,844.8

	December 31, 2019
(In millions)	U.S.		Europe(1)		Germany		Asia		Other		Total
Product revenue from external customers	$	6,713.8	$	2,668.4	$	1,126.1	$	320.3	$	551.2	$	11,379.8
Revenue from anti-CD20 therapeutic programs	2,211.9		0.2		—		—		78.3		2,290.4
Other revenue from external customers	585.8		9.4		0.3		112.2		—		707.7
Long-lived assets	1,493.2		2,135.4		27.5		6.2		12.0		3,674.3

(1) Represents amounts related to Europe less those attributable to Germany.